Home Cart Sign in  
Chemical Structure| 97-77-8 Chemical Structure| 97-77-8

Structure of Disulfiram
CAS No.: 97-77-8

Chemical Structure| 97-77-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Disulfiram is a specific inhibitor of aldehyde-dehydrogenase (ALDH1), used for the treatment of chronic alcoholism by producing an acute sensitivity to alcohol. Disulfiram acts as an allosteric inhibitor of MERS-CoV PLpro but as a competitive (or mixed) inhibitor of SARS-CoV PLpro. It also inhibits pyroptosis by blocking gasdermin D pore formation.

Synonyms: Tetraethylthiuram disulfide; TETD; Disulfan

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Disulfiram

CAS No. :97-77-8
Formula : C10H20N2S4
M.W : 296.54
SMILES Code : S=C(SSC(N(CC)CC)=S)N(CC)CC
Synonyms :
Tetraethylthiuram disulfide; TETD; Disulfan
MDL No. :MFCD00009048
InChI Key :AUZONCFQVSMFAP-UHFFFAOYSA-N
Pubchem ID :3117

Safety of Disulfiram

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H319-H372-H410
Precautionary Statements:P501-P273-P260-P270-P264-P280-P391-P314-P337+P313-P305+P351+P338-P301+P312+P330
Class:9
UN#:3077
Packing Group:

Isoform Comparison

Biological Activity

Target
  • Dehydrogenase

In Vitro:

Cell Line
Concentration Treated Time Description References
961C cells 2 μM 48 hours Evaluate the inhibitory effect of DS on NUP98–PHF23 expressing cells, showing robust inhibition of 961C cell survival Nat Commun. 2020 Jul 3;11(1):3339
748T cells 2.2 μM 96 hours Evaluate the inhibitory effect of AD on NUP98–PHF23 expressing cells, showing modest inhibition of 748T cell survival Nat Commun. 2020 Jul 3;11(1):3339

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice Pristane-induced lupus model Intraperitoneal injection 50 mg/kg 14 weeks To evaluate the therapeutic effect of DSF on PIL mice, results showed DSF alleviated lupus-associated symptoms Cell Death Discov. 2022 Sep 3;8(1):379

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00372749 Alcoholic Intoxication, Chroni... More >>c Less << Not Applicable Completed - France ... More >> Hopital Emile Roux APHP Limeil-Brevannes, France, 94450 Less <<
NCT02309801 Healthy Phase 1 Completed - Spain ... More >> Parc de Salut Mar. Barcelona, Spain, 08003 Less <<
NCT02770378 Glioblastoma Phase 1 Active, not recruiting March 2020 Germany ... More >> University of Ulm School of Medicine Ulm, Baden-Württemberg, Germany, 89081 Less <<
NCT01186172 Bacteremia Phase 3 Unknown June 2013 Italy ... More >> Fondazione IRCCS Policlinico "San Matteo" Recruiting Pavia, PV, Italy, 27100 Principal Investigator: Michele Pagani, M.D.          Sub-Investigator: Andrea Bottazzi, M.D. Less <<
NCT00986791 Acute Fracture Surgery ... More >> Alcohol Cessation Intervention Postoperative Complications Infection Ankle Injuries Less << Not Applicable Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Copenhagen, Denmark, 2650 Hospital Of South West Denmark Aabenraa, Denmark Bispebjerg University Hospital Copenhagen, Denmark Less <<
NCT00218660 Alcoholism Co... More >>caine Dependence Less << Phase 3 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 6178 Less <<
NCT00659230 Posttraumatic Stress Disorder Phase 2 Completed - United States, Alabama ... More >> Tuscaloosa VAMC Tuscaloosa, Alabama, United States, 35404 United States, California VA San Diego Healthcare System San Diego, California, United States, 92161 United States, New York James J.Peters VA Medical Center The Bronx, New York, United States, 10468 Less <<
NCT00659230 - Completed - -
NCT02771925 Alcohol Dependence Phase 4 Unknown May 2018 India ... More >> Dyanand Medical College and Hospital Recruiting Ludhiana, Punjab, India, 141001 Contact: Sandeep Singh Sidhu, MD,DM    +919814025085    sandeepsidhu1963@gmail.com    Contact: Omesh Goyal, MD,DM    +919914821155    goyalomesh@yahoo.co.in    Principal Investigator: Sandeep Singh Sidhu, MD,DM Less <<
NCT00167232 Cocaine Dependence ... More >> Alcoholism Less << Phase 3 Completed - United States, Pennsylvania ... More >> University of Pennsylvania- Treatment Research Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00435435 Alcohol Dependence Phase 4 Completed - Finland ... More >> National Public Health Institute, Department of Mental Health and Alcohol Research Helsinki, Finland, 00251 Less <<
NCT01343628 Alcohol-induced Cue-craving ... More >> Alcohol Sensitivity Less << Phase 1 Terminated(Terminated due to l... More >>ack of funding) Less << - United States, Virginia ... More >> Center for Addiction Research and Education Charlottesville/ Richmond, Virginia, United States, 22903 Less <<
NCT00729300 Cocaine Addiction Phase 1 Phase 2 Terminated(Project moved to ne... More >>w university) Less << - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77056 Less <<
NCT03469128 Psychologic Manipulation Phase 1 Completed - -
NCT02715609 Glioblastoma Multiforme Phase 1 Phase 2 Suspended(Waiting to see if a ... More >>dose expansion phase will be added) Less << February 28, 2022 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00431262 Alcoholism Phase 4 Unknown - Denmark ... More >> Psykiatrisk Center Gentofte Recruiting Hellerup, Denmark, 2900 Contact: Jakob Ulrichsen, MD, ph.d.    (45) 3977 3650    jaul@geh.regionh.dk    Principal Investigator: Jakob Ulrichsen, MD, ph.d. Less <<
NCT00350870 - Completed - -
NCT00655967 Alcohol Dependence Phase 4 Unknown December 2008 United States, New Mexico ... More >> University of New Mexico Recruiting Albuquerque, New Mexico, United States, 87131-0001 Contact: Florian Birkmayer, M.D.    505-272-2223    fbirkmayer@salud.unm.edu    Sub-Investigator: Michael Bogenschutz, M.D. Less <<
NCT01437046 Alcohol Dependence ... More >> Anxiety Less << Phase 2 Completed - United States, Rhode Island ... More >> Brown University Center for Alcohol and Addiction Studies Providence, Rhode Island, United States, 02903 Less <<
NCT00142844 Alcohol-Related Disorders ... More >> Alcoholism Cocaine-Related Disorders Less << Phase 2 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 6178 Less <<
NCT03714555 Metastatic Pancreatic Cancer Phase 2 Not yet recruiting November 1, 2020 -
NCT03543735 Drinking, Alcohol Phase 2 Recruiting April 30, 2021 United States, Rhode Island ... More >> Butler Hospital Recruiting Providence, Rhode Island, United States, 02906 Contact: Claire E Blevins, PhD Less <<
NCT00094289 Alcohol-Related Disorders|Coca... More >>ine-Related Disorders Less << PHASE1 UNKNOWN 2025-07-05 UCLA Integrated Substance Abus... More >>e Program, Los Angeles, California, 90024, United States|University of Texas Hlth Sci Ctr San Ant, San Antonio, Texas, 78284 7828, United States Less <<
NCT00350870 Cocaine Abuse Phase 1 Completed - United States, Connecticut ... More >> APT Foundation New Haven, Connecticut, United States, 06510 Less <<
NCT00000278 Alcohol-Related Disorders|Coca... More >>ine-Related Disorders Less << PHASE2 COMPLETED 1999-08-01 VA Connecticut Healthcare Syst... More >>em, New Haven, Connecticut, 06519, United States Less <<
NCT00312819 Non-small Cell Lung Cancer Phase 2 Phase 3 Completed - Israel ... More >> Oncology Institute Meir Medical Center Kfar Saba, Israel Less <<
NCT01118741 Prostate Cancer COMPLETED 2025-06-12 Johns Hopkins Hospital, Baltim... More >>ore, Maryland, 21231, United States|Duke University, Durham, North Carolina, 27710, United States|Thomas Jefferson Universith, Philadelphia, Pennsylvania, 19107, United States Less <<
NCT00002065 HIV Infections COMPLETED - Saint Vincent's Med Ctr, State... More >>n Island, New York, 10310, United States Less <<
NCT03151772 Glioblastoma Early Phase 1 Recruiting June 2019 Sweden ... More >> Sahlgrenska University Hospital Recruiting Göteborg, Sweden Contact: Louise Carstam, MD Less <<
NCT02963051 Prostate Cancer Phase 1 Recruiting August 2022 United States, North Carolina ... More >> Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Julia Rasmussen, MS, RN, BSN    919-681-1030    julia.rasmussen@duke.edu Less <<
NCT02671890 Metastatic Pancreatic Adenocar... More >>cinoma Recurrent Pancreatic Carcinoma Solid Neoplasm Stage IV Pancreatic Cancer Less << Phase 1 Suspended(per protocol) May 5, 2021 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00580827 Cocaine-Related Disorder ... More >> Opiate Dependence Less << Not Applicable Completed - United States, Connecticut ... More >> West Haven VA West Haven, Connecticut, United States, 06516 Less <<
NCT00256230 Stage IV Melanoma Phase 1 Phase 2 Completed - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT02134002 Cocaine Dependence Phase 4 Withdrawn(Too selective recrut... More >>ment criteria, none eligible patients) Less << December 2016 France ... More >> Paul Brousse Hospital Villejuif, France, 94804 Less <<
NCT01118741 Prostate Cancer COMPLETED 2025-06-12 Johns Hopkins Hospital, Baltim... More >>ore, Maryland, 21231, United States|Duke University, Durham, North Carolina, 27710, United States|Thomas Jefferson Universith, Philadelphia, Pennsylvania, 19107, United States Less <<
NCT03034135 Recurrent Glioblastoma Phase 2 Completed - United States, Michigan ... More >> Beaumont Hospital Royal Oak, Michigan, United States, 48073 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey John Theurer Cancer Center Hackensack, New Jersey, United States, 07601 United States, New York Lenox Hill Hospital New York, New York, United States, 10075 United States, Ohio University of Cincinnati Cincinnati, Ohio, United States, 45220 United States, Tennessee Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States, 37212 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112-5550 Less <<
NCT02101008 Melanoma Phase 2 Completed - -
NCT01777919 Glioblastoma Multiforme Phase 2 Not yet recruiting January 2020 Greece ... More >> Olympion Medical Center Not yet recruiting Patras, Greece, 26443 Contact: Petros N Karamanakos, MD, PhD          Principal Investigator: Petros N Karamanakos, MD, PhD Less <<
NCT02101008 - Completed - -
NCT00913484 Cocaine Dependence ... More >> Opioid Dependency Less << Phase 2 Completed - United States, Connecticut ... More >> The APT Foundation MRU New Haven, Connecticut, United States, 06519 Yale University School of Medicine New Haven, Connecticut, United States, 06519 Less <<
NCT00395850 Cocaine Dependence PHASE2 COMPLETED 2025-12-11 University of Arkansas for Med... More >>ical Sciences, Little Rock, Arkansas, 72205, United States Less <<
NCT00395850 Cocaine Dependence PHASE2 COMPLETED 2025-12-11 University of Arkansas for Med... More >>ical Sciences, Little Rock, Arkansas, 72205, United States Less <<
NCT02678975 Glioma Gliobl... More >>astoma Less << Phase 2 Phase 3 Recruiting September 2020 Norway ... More >> Cancer Clinic, St.Olavs University Hospital Recruiting Trondheim, Norway Contact: Tora S Solheim, MD, PhD          Principal Investigator: Tora S Solheim, MD, PhD          Sweden Dept. of Oncology, Sahlgrenska University Hospital Recruiting Gothenburg, Sweden Contact: Katja Werlenius, MD          Principal Investigator: Katja Werlenius, MD          Ryhov County Hospital Recruiting Jönköping, Sweden Contact: Michael Strandéus, MD          Principal Investigator: Michael Strandéus, MD          Linköping University Hospital Recruiting Linkoping, Sweden Contact: Munila Mudaisi, MD          Principal Investigator: Munila Mudaisi, MD          Lund University Hospital Recruiting Lund, Sweden Contact: Sara Kinhult, MD, PhD          Principal Investigator: Sara Kinhult, MD, PhD          Karolinska University Hospital Recruiting Stockholm, Sweden Contact: Sofia Hylin, MD          Principal Investigator: Sofia Hylin, MD          Uppsala University Hospital Recruiting Uppsala, Sweden Contact: Magnus Lindskog, MD, PhD          Principal Investigator: Magnus Lindskog, MD, PHD          Örebro University Hospital Recruiting Örebro, Sweden Contact: David Löfgren, MD          Principal Investigator: David Löfgren, MD Less <<
NCT01907165 Glioblastoma Early Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00721526 Alcohol Dependence ... More >> Anxiety Disorder Less << Phase 4 Completed - United States, New Mexico ... More >> University of New Mexico Addiction and Substance Abuse Programs Albuquerque, New Mexico, United States, 87106 Less <<
NCT00149630 Cocaine Dependence ... More >> Opioid Dependence Less << Phase 2 Completed - United States, Texas ... More >> Michael E. DeBakey VA Medical Center Houston, Texas, United States, 77030 Less <<
NCT03363659 Glioblastoma ... More >>Glioblastoma Multiforme Less << Phase 2 Recruiting January 21, 2027 United States, Wisconsin ... More >> Aurora Health Care, Aurora St. Luke's Medical Center Recruiting Milwaukee, Wisconsin, United States, 53215 Contact: Lynda Yanny    414-649-6685    lynda.yanny@aurora.org    Principal Investigator: George Bobustuc, MD          Sub-Investigator: Richard A Rovin, MD          Sub-Investigator: Asad Khan, MD          Sub-Investigator: Amin Kassam, MD          Sub-Investigator: Santhi Konduri, PhD Less <<
NCT00218608 Cocaine-Related Disorders|Opio... More >>id-Related Disorders Less << PHASE2 COMPLETED 2025-01-07 University of Arkansas for Med... More >>ical Sciences, Little Rock, Arkansas, 72205 7911, United States Less <<
NCT00742911 Cancer Phase 1 Completed - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT00571116 Metastatic Melanoma Phase 1 Phase 2 Terminated(Halted because of s... More >>low accrual and lack of study funding) Less << - United States, California ... More >> Chao Family Comprehensive Cancer Center, University of California, Irvine Orange, California, United States, 92868 Less <<
NCT03198559 HIV Infections Phase 1 Phase 2 Suspended(Review of current ad... More >>verse events reported by study participants) Less << July 2027 Australia, Victoria ... More >> Department of Infectious Diseases, Alfred Hospital Melbourne, Victoria, Australia, 3004 Less <<
NCT00149630 - Completed - -
NCT01286259 HIV-1 Infection COMPLETED 2025-05-14 San Francisco General Hospital... More >>, San Francisco, California, 94110, United States|Johns Hopkins University, Baltimore, Maryland, 21205, United States Less <<
NCT00731133 Methamphetamine Dependence PHASE1|PHASE2 COMPLETED 2025-09-10 University of Arkansas for Med... More >>ical Sciences, Little Rock, Arkansas, 72205, United States Less <<
NCT01944371 HIV|Human Immunodeficiency Vir... More >>us Less << PHASE1|PHASE2 COMPLETED 2025-05-14 San Francisco General Hospital... More >>, San Francisco, California, 94110, United States|Alfred Hospital, Melbourne, 3004, Australia Less <<
NCT00731133 Methamphetamine Dependence PHASE1|PHASE2 COMPLETED 2025-09-10 University of Arkansas for Med... More >>ical Sciences, Little Rock, Arkansas, 72205, United States Less <<
NCT00878306 HIV Infections ... More >> Drug Abuse Less << Phase 1 Completed - United States, California ... More >> San Francisco General Hospital San Francisco, California, United States, 94110 Less <<
NCT03212599 Alcohol Addiction COMPLETED 2025-07-17 -
NCT03323346 Breast Neoplasm Female|Metasta... More >>tic Breast Cancer Less << PHASE2 RECRUITING 2025-12-31 University Hospital Olomouc, O... More >>lomouc, 77900, Czechia Less <<
NCT02735577 Alcohol Use Disorder PHASE4 COMPLETED 2020-10-16 NYPInstitute, New York, New Yo... More >>rk, 10032, United States Less <<
NCT03891667 Fatigue|Quality of Life PHASE1|PHASE2 COMPLETED 2022-03-31 Lyme Research Center New York ... More >>State Psychiatric Institute, New York, New York, 10032, United States Less <<
NCT03950830 Germ Cell Tumor PHASE2 COMPLETED 2022-01-31 National Cancer Institute, Bra... More >>tislava, 83310, Slovakia Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.37mL

0.67mL

0.34mL

16.86mL

3.37mL

1.69mL

33.72mL

6.74mL

3.37mL

References

 

Historical Records

Categories